Click here to get full coverage on Kura Oncology Q4 Earnings Call Highlights - Yahoo Finance

Kura Oncology Q4 Earnings Call Highlights  Yahoo Finance

Kura Oncology Q4 Earnings Call Highlights - Yahoo Finance

Click here to get full coverage on Kura says its menin inhibitor is preferred treatment for a 'handful' of payers - Endpoints News

Kura says its menin inhibitor is preferred treatment for a 'handful' of payers  Endpoints News

Kura says its menin inhibitor is preferred treatment for a 'handful' of payers - Endpoints News

Click here to get full coverage on Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates  Nasdaq

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq

Click here to get full coverage on Kura Oncology Earnings Call Highlights Comzifty Launch - TipRanks

Kura Oncology Earnings Call Highlights Comzifty Launch  TipRanks

Kura Oncology Earnings Call Highlights Comzifty Launch - TipRanks

Click here to get full coverage on Kura Oncology: Q4 Earnings Snapshot - king5.com

Kura Oncology: Q4 Earnings Snapshot  king5.com

Kura Oncology: Q4 Earnings Snapshot - king5.com

Click here to get full coverage on Kura Oncology (KURA) Reports Strong Q4 2025 with KOMZIFTI Launch - GuruFocus

Kura Oncology (KURA) Reports Strong Q4 2025 with KOMZIFTI Launch  GuruFocus

Kura Oncology (KURA) Reports Strong Q4 2025 with KOMZIFTI Launch - GuruFocus

Click here to get full coverage on KURA ONCOLOGY ($KURA) Releases Q4 2025 Earnings - Quiver Quantitative

KURA ONCOLOGY ($KURA) Releases Q4 2025 Earnings  Quiver Quantitative

KURA ONCOLOGY ($KURA) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Earnings call transcript: Kura Oncology Q4 2025 sees significant earnings miss, stock dips - Investing.com

Earnings call transcript: Kura Oncology Q4 2025 sees significant earnings miss, stock dips  Investing.com

Earnings call transcript: Kura Oncology Q4 2025 sees significant earnings miss, stock dips - Investing.com

Click here to get full coverage on Kura Oncology (NASDAQ:KURA) Shares Gap Down After Earnings Miss - MarketBeat

Kura Oncology (NASDAQ:KURA) Shares Gap Down After Earnings Miss  MarketBeat

Kura Oncology (NASDAQ:KURA) Shares Gap Down After Earnings Miss - MarketBeat

Click here to get full coverage on Cancer pill KOMZIFTI begins sales as Kura posts $81M loss - Stock Titan

Cancer pill KOMZIFTI begins sales as Kura posts $81M loss  Stock Titan

Cancer pill KOMZIFTI begins sales as Kura posts $81M loss - Stock Titan

Click here to get full coverage on KURA: KOMZIFTI launch drove initial sales and strong cash reserves, with pipeline and R&D expansion ongoing - TradingView

KURA: KOMZIFTI launch drove initial sales and strong cash reserves, with pipeline and R&D expansion ongoing  TradingView

KURA: KOMZIFTI launch drove initial sales and strong cash reserves, with pipeline and R&D expansion ongoing - TradingView

Click here to get full coverage on Kura Sushi Bets on Patents, Smart Tech and Sustainability to Keep Conveyor-Belt Sushi Fresh Worldwide - The Worldfolio

Kura Sushi Bets on Patents, Smart Tech and Sustainability to Keep Conveyor-Belt Sushi Fresh Worldwide  The Worldfolio

Kura Sushi Bets on Patents, Smart Tech and Sustainability to Keep Conveyor-Belt Sushi Fresh Worldwide - The Worldfolio

Click here to get full coverage on Wedbush Cuts Kura Oncology Price Target to $36 From $38, Outperform Rating Maintained - marketscreener.com

Wedbush Cuts Kura Oncology Price Target to $36 From $38, Outperform Rating Maintained  marketscreener.com

Wedbush Cuts Kura Oncology Price Target to $36 From $38, Outperform Rating Maintained - marketscreener.com

Click here to get full coverage on Kura Oncology Q4 Earnings Summary & Key Takeaways - Benzinga

Kura Oncology Q4 Earnings Summary & Key Takeaways  Benzinga

Kura Oncology Q4 Earnings Summary & Key Takeaways - Benzinga

Click here to get full coverage on Kura Oncology Inc. Q4 Loss Increases - Nasdaq

Kura Oncology Inc. Q4 Loss Increases  Nasdaq

Kura Oncology Inc. Q4 Loss Increases - Nasdaq

Click here to get full coverage on Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZI - GuruFocus

Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZI  GuruFocus

Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZI - GuruFocus

Click here to get full coverage on Kura Oncology (NASDAQ:KURA) Releases Earnings Results, Misses Estimates By $0.50 EPS - MarketBeat

Kura Oncology (NASDAQ:KURA) Releases Earnings Results, Misses Estimates By $0.50 EPS  MarketBeat

Kura Oncology (NASDAQ:KURA) Releases Earnings Results, Misses Estimates By $0.50 EPS - MarketBeat

Click here to get full coverage on KURA: Early KOMZIFTI launch success and robust cash position support pivotal clinical progress - TradingView

KURA: Early KOMZIFTI launch success and robust cash position support pivotal clinical progress  TradingView

KURA: Early KOMZIFTI launch success and robust cash position support pivotal clinical progress - TradingView

Click here to get full coverage on Kura Oncology Inc expected to post a loss of 61 cents a share - Earnings Preview - TradingView

Kura Oncology Inc expected to post a loss of 61 cents a share - Earnings Preview  TradingView

Kura Oncology Inc expected to post a loss of 61 cents a share - Earnings Preview - TradingView

Click here to get full coverage on KURA: KOMZIFTI drives growth in AML as broad pipeline and phase 3 trials advance toward 2026 - TradingView

KURA: KOMZIFTI drives growth in AML as broad pipeline and phase 3 trials advance toward 2026  TradingView

KURA: KOMZIFTI drives growth in AML as broad pipeline and phase 3 trials advance toward 2026 - TradingView

Click here to get full coverage on Kura Sushi USA, Inc. $KRUS Stock Position Raised by Royce & Associates LP - MarketBeat

Kura Sushi USA, Inc. $KRUS Stock Position Raised by Royce & Associates LP  MarketBeat

Kura Sushi USA, Inc. $KRUS Stock Position Raised by Royce & Associates LP - MarketBeat

Click here to get full coverage on A Glimpse of Kura Oncology's Earnings Potential - Benzinga

A Glimpse of Kura Oncology's Earnings Potential  Benzinga

A Glimpse of Kura Oncology's Earnings Potential - Benzinga

Click here to get full coverage on Kura Oncology (KURA) Faces Mixed Financial Results Amid Promisin - GuruFocus

Kura Oncology (KURA) Faces Mixed Financial Results Amid Promisin  GuruFocus

Kura Oncology (KURA) Faces Mixed Financial Results Amid Promisin - GuruFocus

Click here to get full coverage on Arcos Dorados, Red Robin, Yum China, Cracker Barrel, and Kura Sushi Shares Are Falling, What You Need To Know - TradingView

Arcos Dorados, Red Robin, Yum China, Cracker Barrel, and Kura Sushi Shares Are Falling, What You Need To Know  TradingView

Arcos Dorados, Red Robin, Yum China, Cracker Barrel, and Kura Sushi Shares Are Falling, What You Need To Know - TradingView

Click here to get full coverage on KURA: Komzifti's launch and broad clinical pipeline drive growth, with strong cash reserves supporting expansion - TradingView

KURA: Komzifti's launch and broad clinical pipeline drive growth, with strong cash reserves supporting expansion  TradingView

KURA: Komzifti's launch and broad clinical pipeline drive growth, with strong cash reserves supporting expansion - TradingView

Click here to get full coverage on Kura Oncology (KURA) Set to Release Q4 Earnings - GuruFocus

Kura Oncology (KURA) Set to Release Q4 Earnings  GuruFocus

Kura Oncology (KURA) Set to Release Q4 Earnings - GuruFocus

Click here to get full coverage on Kura Sushi to open second location in San Diego - fox5sandiego.com

Kura Sushi to open second location in San Diego  fox5sandiego.com

Kura Sushi to open second location in San Diego - fox5sandiego.com

Click here to get full coverage on Kura Sushi Hangs On to Diners Despite Price Increases - WSJ

Kura Sushi Hangs On to Diners Despite Price Increases  WSJ

Kura Sushi Hangs On to Diners Despite Price Increases - WSJ

Click here to get full coverage on Guinness honors Kura Sushi for most conveyor-belt eateries - 朝日新聞

Guinness honors Kura Sushi for most conveyor-belt eateries  朝日新聞

Guinness honors Kura Sushi for most conveyor-belt eateries - 朝日新聞

Click here to get full coverage on Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on ASH 2025 – Kura seeks further safety edge | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

ASH 2025 – Kura seeks further safety edge | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

ASH 2025 – Kura seeks further safety edge | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on Edward Martin Kura - View Obituary & Service Information - Sam Houston Memorial Funeral Home

Edward Martin Kura - View Obituary & Service Information  Sam Houston Memorial Funeral Home

Edward Martin Kura - View Obituary & Service Information - Sam Houston Memorial Funeral Home

Click here to get full coverage on Kura Sushi USA and Sanrio® Bring Smiles with Hello Kitty® and Friends Bikkura Pon Dining Experience - PR Newswire

Kura Sushi USA and Sanrio® Bring Smiles with Hello Kitty® and Friends Bikkura Pon Dining Experience  PR Newswire

Kura Sushi USA and Sanrio® Bring Smiles with Hello Kitty® and Friends Bikkura Pon Dining Experience - PR Newswire

Click here to get full coverage on Kura Oncology (NASDAQ:KURA) Upgraded at Zacks Research - MarketBeat

Kura Oncology (NASDAQ:KURA) Upgraded at Zacks Research  MarketBeat

Kura Oncology (NASDAQ:KURA) Upgraded at Zacks Research - MarketBeat

Click here to get full coverage on Kura Sushi, Dine Brands, BJ's, Red Robin, and Texas Roadhouse Shares Are Falling, What You Need To Know - Yahoo Finance

Kura Sushi, Dine Brands, BJ's, Red Robin, and Texas Roadhouse Shares Are Falling, What You Need To Know  Yahoo Finance

Kura Sushi, Dine Brands, BJ's, Red Robin, and Texas Roadhouse Shares Are Falling, What You Need To Know - Yahoo Finance

Click here to get full coverage on Kura harks back to its roots | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Kura harks back to its roots | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Kura harks back to its roots | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates - Investing.com India

Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates  Investing.com India

Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates - Investing.com India

Click here to get full coverage on Kura Oncology to Participate in Three Upcoming Investor Conferences - GlobeNewswire

Kura Oncology to Participate in Three Upcoming Investor Conferences  GlobeNewswire

Kura Oncology to Participate in Three Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire

Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results  GlobeNewswire

Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire

Click here to get full coverage on Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of "Moderate Buy" by Brokerages  MarketBeat

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on Kura gets a safety edge over Syndax | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Kura gets a safety edge over Syndax | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Kura gets a safety edge over Syndax | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on US approval for Kura's Komzifti sets up menin rivalry with Syndax in AML - FirstWord Pharma

US approval for Kura's Komzifti sets up menin rivalry with Syndax in AML  FirstWord Pharma

US approval for Kura's Komzifti sets up menin rivalry with Syndax in AML - FirstWord Pharma

Click here to get full coverage on Fault creep in the fluid-rich Kura Basin, Azerbaijan, imaged with InSAR - Oxford Academic

Fault creep in the fluid-rich Kura Basin, Azerbaijan, imaged with InSAR  Oxford Academic

Fault creep in the fluid-rich Kura Basin, Azerbaijan, imaged with InSAR - Oxford Academic

Click here to get full coverage on Fun revolving sushi bar Kura sets opening date in Pflugerville - CultureMap Austin

Fun revolving sushi bar Kura sets opening date in Pflugerville  CultureMap Austin

Fun revolving sushi bar Kura sets opening date in Pflugerville - CultureMap Austin

Click here to get full coverage on Kura Oncology secures approval for leukemia drug, its first - statnews.com

Kura Oncology secures approval for leukemia drug, its first  statnews.com

Kura Oncology secures approval for leukemia drug, its first - statnews.com

Click here to get full coverage on FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma - MedCity News

FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma  MedCity News

FDA Approves Kura Oncology Leukemia Drug, Teeing Up Competition With Syndax Pharma - MedCity News

Click here to get full coverage on Jim Cramer Discusses Kura Oncology as a Speculative Bet - Yahoo Finance

Jim Cramer Discusses Kura Oncology as a Speculative Bet  Yahoo Finance

Jim Cramer Discusses Kura Oncology as a Speculative Bet - Yahoo Finance

Click here to get full coverage on Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML - Pharmaceutical Executive

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML  Pharmaceutical Executive

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML - Pharmaceutical Executive

Click here to get full coverage on Syndax and Kura go head to head again | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Syndax and Kura go head to head again | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Syndax and Kura go head to head again | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on Bluebird partners ask KURA to nearly double its contribution - Idaho Mountain Express Newspaper

Bluebird partners ask KURA to nearly double its contribution  Idaho Mountain Express Newspaper

Bluebird partners ask KURA to nearly double its contribution - Idaho Mountain Express Newspaper

Click here to get full coverage on How the Narrative Surrounding Kura Oncology Is Changing After Komzifti Approval - Yahoo Finance

How the Narrative Surrounding Kura Oncology Is Changing After Komzifti Approval  Yahoo Finance

How the Narrative Surrounding Kura Oncology Is Changing After Komzifti Approval - Yahoo Finance

Click here to get full coverage on Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy - Pharmaceutical Technology

Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy  Pharmaceutical Technology

Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy - Pharmaceutical Technology

Click here to get full coverage on Stocks Flashing Renewed Technical Strength: Kura Sushi USA - Investor's Business Daily

Stocks Flashing Renewed Technical Strength: Kura Sushi USA  Investor's Business Daily

Stocks Flashing Renewed Technical Strength: Kura Sushi USA - Investor's Business Daily

Click here to get full coverage on Hood River reports 5.3% stake in Kura Sushi USA (NASDAQ: KRUS) - Stock Titan

Hood River reports 5.3% stake in Kura Sushi USA (NASDAQ: KRUS)  Stock Titan

Hood River reports 5.3% stake in Kura Sushi USA (NASDAQ: KRUS) - Stock Titan

Click here to get full coverage on Kura Oncology (KURA) Gains Momentum as Barclays Sees Significant Potential in Ziftomenib Approval - Yahoo Finance

Kura Oncology (KURA) Gains Momentum as Barclays Sees Significant Potential in Ziftomenib Approval  Yahoo Finance

Kura Oncology (KURA) Gains Momentum as Barclays Sees Significant Potential in Ziftomenib Approval - Yahoo Finance

Click here to get full coverage on Is it time to get into biopharma player Kura Oncology? Jim Cramer digs in - CNBC

Is it time to get into biopharma player Kura Oncology? Jim Cramer digs in  CNBC

Is it time to get into biopharma player Kura Oncology? Jim Cramer digs in - CNBC

Click here to get full coverage on Why The Narrative Around Kura Oncology Is Shifting After Komzifti’s FDA Breakthrough - Yahoo Finance

Why The Narrative Around Kura Oncology Is Shifting After Komzifti’s FDA Breakthrough  Yahoo Finance

Why The Narrative Around Kura Oncology Is Shifting After Komzifti’s FDA Breakthrough - Yahoo Finance

Click here to get full coverage on Kura moves forward with Sh7.6bn Outer Ring BRT project - Daily Nation

Kura moves forward with Sh7.6bn Outer Ring BRT project  Daily Nation

Kura moves forward with Sh7.6bn Outer Ring BRT project - Daily Nation

Click here to get full coverage on Kura Oncology (KURA): Persistent Losses Undercut Rapid 42.7% Revenue Growth Narrative - Yahoo Finance

Kura Oncology (KURA): Persistent Losses Undercut Rapid 42.7% Revenue Growth Narrative  Yahoo Finance

Kura Oncology (KURA): Persistent Losses Undercut Rapid 42.7% Revenue Growth Narrative - Yahoo Finance

Click here to get full coverage on Raukura of Aho Matua kura Tukaha Cooper steps onto the Breakers court - Te Ao Māori News

Raukura of Aho Matua kura Tukaha Cooper steps onto the Breakers court  Te Ao Māori News

Raukura of Aho Matua kura Tukaha Cooper steps onto the Breakers court - Te Ao Māori News

Click here to get full coverage on Nintendo’s Kirby now delivering orders at Kura Sushi restaurants, but not in Japan - SoraNews24

Nintendo’s Kirby now delivering orders at Kura Sushi restaurants, but not in Japan  SoraNews24

Nintendo’s Kirby now delivering orders at Kura Sushi restaurants, but not in Japan - SoraNews24

Click here to get full coverage on Kirby Has Arrived at Kura Sushi - License Global

Kirby Has Arrived at Kura Sushi  License Global

Kirby Has Arrived at Kura Sushi - License Global

Click here to get full coverage on Kura Revolving Sushi Bar to serve Japanese cuisine in Denton - Community Impact | News

Kura Revolving Sushi Bar to serve Japanese cuisine in Denton  Community Impact | News

Kura Revolving Sushi Bar to serve Japanese cuisine in Denton - Community Impact | News

Click here to get full coverage on Kura scores FDA okay for rival to Syndax's leukaemia drug - pharmaphorum

Kura scores FDA okay for rival to Syndax's leukaemia drug  pharmaphorum

Kura scores FDA okay for rival to Syndax's leukaemia drug - pharmaphorum

Click here to get full coverage on How Recent Events Are Rewriting the Story for Kura Oncology - Yahoo Finance

How Recent Events Are Rewriting the Story for Kura Oncology  Yahoo Finance

How Recent Events Are Rewriting the Story for Kura Oncology - Yahoo Finance

Click here to get full coverage on Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML - Yahoo Finance

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML  Yahoo Finance

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML - Yahoo Finance

Click here to get full coverage on Kura Sushi sees signs of a thawing consumer - Restaurant Business

Kura Sushi sees signs of a thawing consumer  Restaurant Business

KURA

Price Chart

Key Statistics

Technicals

About KURA

Latest News

Kura Oncology Q4 Earnings Call Highlights - Yahoo Finance

Kura says its menin inhibitor is preferred treatment for a 'handful' of payers - Endpoints News

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq

Advanced Charts

Top Gainers

Top Losers